Pictet-Biotech R EUR

Analyst Report
Morningstar's Take
|29/02/2024

by Morningstar Manager Research
*  This rating and report were issued for a different share class of this fund. The performance and fee structure of this class may vary from that referenced.

Strength in Pictet-Biotech R EUR's People Pillar is partially offset by an Average Process Pillar rating, leading to a Morningstar Medalist Rating of Neutral. Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the most expensive quintile among peers.



The strategy gets an Average Process Pillar. Independent of the rating, analysis of the strategy's portfolio shows it is currently, although not consistently, overweight in volatility exposure and momentum exposure compared with category peers. High volatility exposure is attributed to companies with a higher standard deviation of returns. And momentum exposure is rooted in holding stocks currently on a winning streak. The strategy's management team has a high retention rate, which helps continuity and earns it an Above Average People Pillar rating. The strategy's parent organization earns the firm an Above Average Parent Pillar rating, and this rating is inherited from vehicles belonging to the same branding entity and is indirectly assigned by an analyst.

 
Morningstar Medalist Rating™
To find out how Morningstar rates a fund click here.
Morningstar Pillars
PeopleAbove Average
ParentAbove Average
ProcessAverage
 
Morningstar Medalist RatingMorningstar assigns the Medalist Rating to funds that are qualitatively and quantitatively assessed through manager research and algorithmic processes. The assessment turns on three key “pillars” – People, Process, and Parent – that yield an estimate of how well a fund will perform before fees but after adjusting for risk.
Permissions/Reprints   E-mail Morningstar     
A fim de prover consistência para todos os relatórios fornecidos por diferentes Asset Managers, os data points calculados apresentados são gerados usando uma metodologia de cálculo proprietária da Morningstar, que pode ser conferida com mais detalhes em(https://www.morningstar.com/research/signature)
© Copyright 2024 Morningstar, Inc. Todos os direitos reservados.

Termos de Uso        Política Privacidade        Cookie Settings        Divulgações